XML 75 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restructuring and Related Charges (Tables)
12 Months Ended
Sep. 27, 2013
Restructuring Charges [Abstract]  
Schedule of Restructuring and Related Charges by Segment
Net restructuring and related charges by segment are as follows:
 
Fiscal Year
 
2013
 
2012
 
2011
Specialty Pharmaceuticals
$
16.4

 
$
11.3

 
$
6.5

Global Medical Imaging
16.4

 
7.9

 
3.8

Corporate
3.0

 

 
(0.3
)
Restructuring and related charges, net
35.8

 
19.2

 
10.0

Less: accelerated depreciation
(2.6
)
 
(8.0
)
 
(1.6
)
Restructuring charges, net
$
33.2

 
$
11.2

 
$
8.4

Schedule of Net Restructuring and Related Charges
Net restructuring and related charges are comprised of the following:
 
Fiscal Year
 
2013
 
2012
 
2011
2013 Mallinckrodt Program
$
14.9

 
$

 
$

Other programs
20.9

 
19.2

 
10.0

Total programs
35.8

 
19.2

 
10.0

Less: non-cash charges, including accelerated depreciation
(2.6
)
 
(6.2
)
 
(1.6
)
Total charges expected to be settled in cash
$
33.2

 
$
13.0

 
$
8.4

Schedule of Restructuring Reserves by Type of Cost
The following table summarizes cash activity for restructuring reserves, substantially all of which related to employee severance and benefits:
 
2013 Mallinckrodt Program
 
Other Programs
 
Total
Balance at September 24, 2010
$

 
$
4.5

 
$
4.5

Charges

 
9.6

 
9.6

Changes in estimate

 
(1.2
)
 
(1.2
)
Cash payments

 
(3.5
)
 
(3.5
)
Reclassifications (1)

 
(1.6
)
 
(1.6
)
Currency translation

 
(0.2
)
 
(0.2
)
Balance at September 30, 2011

 
7.6

 
7.6

Charges

 
12.8

 
12.8

Changes in estimate

 
0.2

 
0.2

Cash payments

 
(11.5
)
 
(11.5
)
Reclassifications (1)

 
(0.2
)
 
(0.2
)
Balance at September 28, 2012

 
8.9

 
8.9

Charges
14.9

 
20.9

 
35.8

Changes in estimate

 
(2.6
)
 
(2.6
)
Cash payments

 
(15.1
)
 
(15.1
)
Reclassifications (1)

 
(1.5
)
 
(1.5
)
Balance at September 27, 2013
$
14.9

 
$
10.6

 
$
25.5


(1)
Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations, and the transfer of certain restructuring liabilities in conjunction with the Separation.
Schedule of Restructuring Charges Incurred Cumulative to Date
Net restructuring and related charges, including associated asset impairments, incurred cumulative to date related to the 2013 Mallinckrodt Program are as follows:
Specialty Pharmaceuticals
$
2.4

Global Medical Imaging
9.5

Corporate
3.0

 
$
14.9